Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes

Molecular Pharmacology

Volumn 64, Issue 3, 2003, Pages 578-586

  Mourlevat, Sophie ^a   Troadec, Jean Denis ^a   Ruberg, Merle ^a   Michel, Patrick P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYCLIC AMP; CYCLIN DEPENDENT KINASE 1; CYTARABINE; EPIDERMAL GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; OLOMOUCINE; ROSCOVITINE; VIMENTIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASTROCYTES; CELL DEATH; COCULTURE TECHNIQUES; CYCLIC AMP; DOPAMINE; FEMALE; MESENCEPHALON; NEUROGLIA; NEURONS; RATS; RATS, WISTAR;

EID: 0041353623     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.3.578     Document Type: Article

References (39)

1. Bayatti N and Engele J (2001) Cyclic AMP modulates the response of central nervous system gha to fibroblast growth factor-2 by redirecting signalling pathways. J Neurochem 78:972-980.
2. Brugg B, Michel PP, Agid Y, and Ruberg M (1996) Ceramide induces apoptosis in cultured mesencephalic neurons. J Neurochem 66:733-739.
3. Dalmau I, Castellano B, Pedersen EB, Finsen B, Zimmer J, and Gonzalez B (1996) Reduction of the microglial cell number in rat primary glial cell cultures by exogenous addition of dibutyryl cyclic adenosine monophosphate. J Neuroimmunol 70:123-129.
4. Deshmukh M and Johnson EM Jr (1997) Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol Pharmacol 51:897-906.
5. + requires concurrent inactivation of NMDA or AMPA/kainate receptors. J Neurochem 78:163-174.
6. Du X and Iacovitti L (1997) Multiple signaling pathways direct the initiation of tyrosine hydroxylase gene expression in cultured brain neurons. Mol Brain Res 50:1-8.
7. Engele J and Franke B (1996) Effects of glial cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways. Cell Tissue Res 286:235-240.
8. Fujita H, Tanaka J, Maeda N, and Sakanaka M (1998) Adrenergic agonists suppress the proliferation of microglia through beta 2-adrenergic receptor. Neurosci Lett 242:37-40.
9. Galli R, Pagano SF, Gritti A, and Vescovi AL (2000) Regulation of neuronal differentiation in human CNS stem cell progeny by leukemia inhibitory factor. Dev Neurosci 22:86-95.
10. Goldberg JL and Barres BA (2000) The relationship between neuronal survival and regeneration. Annu Rev Neurosci 23:579-612.
11. Harrington C and Perrino FW (1995) The effects of cytosine arabinoside on RNA-primed DNA synthesis by DNA polymerase alpha-primase. J Biol Chem 270:26664-26669.
12. +-induced degeneration. J Neurosci Res 32:190-201.
13. Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, and Michel PP (2003) Role of ghal reaction and inflammation in Parkinson's disease. Proc NY Acad Sci 991:214-228.
14. Kawamoto JC and Barrett JN (1986) Cryopreservation of primary neurons for tissue culture. Brain Res 384:84-93.
15. Knockaert M, Greengard P, and Meijer L (2002) Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci 23:417-425.
16. Leutz A and Schachner M (1981) Epidermal growth factor stimulates DNA-synthesis of astrocytes in primary cerebellar cultures. Cell Tissue Res 220:393-404.
17. Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, and Heidenreich KA (2000) Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol Cell Biol 20:9356-9363.
18. Lim J, Yang C, Hong SJ, and Kim KS (2000) Regulation of tyrosine hydroxylase gene transcription by the cAMP-signaling pathway: involvement of multiple transcription factors. Mol Cell Biochem 212:51-60.
19. McKenzie FR, Pouyssegur J (1996) cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases. J Biol Chem 271:13476-8.
20. Malumbres M and Barbacid M (2001) To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1:222-231.
21. Mena MA, Casarejos MJ, Bonin A, Ramos JA, and Garcia Yebenes J (1995) Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: prevention of cell death by dibutyryl cyclic AMP. J Neurochem 65:2612-2620.
22. Meyer-Franke A, Wilkinson GA, Kruttgen A, Hu M, Munro E, Hanson MG Jr, Reichardt LF, and Barres BA (1998) Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron 21:681-693.
23. Michel PP and Agid Y (1996) Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J Neurochem 67:1633-1642.
24. Michel PP, Marien M, Ruberg M, Colpaert F, and Agid Y (1999) Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes. J Neurochem 72:2074-2082.
25. Michel PP, Ruberg M, and Agid Y (1997) Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J Neurochem 69:1499-1507.
26. Riccio A, Ahn S, Davenport CM, Blendy JA, and Ginty DD (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science (Wash DC) 286:2358-2361.
27. Rothman TP, Specht LA, Gershon MD, Joh TH, Teitelman G, Pickel VM, and Reis DJ (1980) Catecholamine biosynthetic enzymes are expressed in replicating cells of the peripheral but not the central nervous system. Proc Natl Acad Sci USA 77:6221-6225.
28. 1 for cell cycle progression induced by bombesin and bradykinin. Am J Physiol 281:C886-C898.
29. Stork PJ and Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266.
30. Streit WJ, Walter SA, and Pennell NA (1999) Reactive microgliosis. Prog Neurobiol 57:563-581.
31. Stull ND, Polan DP, and Iacovitti L (2002) Antioxidant compounds protect dopamine neurons from death due to oxidative stress in vitro. Brain Res 931:181-185.
32. Sutherland EW (1972) Studies on the mechanism of hormone action. Science (Wash DC) 177:401-408.
33. Teismann P, Tieu K, Cohen O, Choi DK, Wu du C, Marks D, Vila M, Jackson-Lewis V, Przedborski S (2003) Pathogenic role of glial cells in Parkinson's disease. Mov Disord 18:121-129.
34. Troadec JD, Marien M, Mourlevat S, Debeir T, Ruberg M, Colpaert F, and Michel PP. (2002) Activation of the mitogen-activated protein kinase (ERK1/2) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. Mol Pharmacol 62:1043-1052.
35. Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H (2000) The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc Natl Acad Sci USA 97:13390-13395.
36. Vesely J, Havlicek L, Strnad M, Blow JJ, Donella-Deana A, Pinna L, Letham DS, Kato J, Detivaud L, Leclerc S, et al. (1994) Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem 224:771-786.
37. Villalba M, Bockaert J, and Journot L (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 17:83-90.
38. Virdee K, Parone PA, and Tolkovsky AM (2000) Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr Biol 10:1151-1154.
39. Wenning GK, Seppi K, Tison F, and Jellinger KA (2002) Novel grading scale for striatonigral degeneration (multiple system atrophy). J Neural Transm 109:307-320.